---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-074822"
form_type: "8-K"
ticker: "GANX"
cik: "0001819411"
company_name: "Gain Therapeutics, Inc."
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:16:02.774199+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Gain Therapeutics stockholders elect eight directors, ratify Ernst & Young as auditor at annual meeting

## Summary
- All eight director nominees elected; broker non-votes of 5,183,098 shares on each nominee.
- Vote totals for directors ranged from 4,308,578 (Hasler) to 6,581,651 (Richman).
- Ernst & Young AG ratified as independent auditor for FY2024: 11,836,784 for, 119,833 against, 35,623 abstain.
- Meeting held June 24, 2024 with quorum present.

## SEC filing metadata
- accession: 0001104659-24-074822
- form_type: 8-K
- ticker: GANX
- cik: 0001819411
- company_name: Gain Therapeutics, Inc.
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819411/000110465924074822/0001104659-24-074822-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819411/000110465924074822/tm2418205d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-074822
- JSON: https://secwatch.observer/filing/0001104659-24-074822.json
- Plain text: https://secwatch.observer/filing/0001104659-24-074822.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.